BlackRock Inc. - AMNEAL PHARMACEUTICALS INC ownership

AMNEAL PHARMACEUTICALS INC's ticker is AMRX and the CUSIP is 03168L105. A total of 169 filers reported holding AMNEAL PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 2.14 and the average weighting 0.1%.

Quarter-by-quarter ownership
BlackRock Inc. ownership history of AMNEAL PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$33,897,189
+36.5%
8,032,509
+0.3%
0.00%0.0%
Q2 2023$24,824,787
+147.0%
8,007,996
+10.8%
0.00%
Q1 2023$10,048,968
-30.8%
7,229,473
-0.9%
0.00%
Q4 2022$14,520,279
+1.8%
7,296,623
+3.3%
0.00%
Q3 2022$14,264,000
-39.8%
7,061,406
-5.3%
0.00%
-100.0%
Q2 2022$23,708,000
-19.7%
7,455,402
+5.3%
0.00%0.0%
Q1 2022$29,535,000
-11.8%
7,082,702
+1.3%
0.00%0.0%
Q4 2021$33,491,000
-9.7%
6,991,630
+0.6%
0.00%0.0%
Q3 2021$37,095,000
+2.1%
6,946,889
-2.1%
0.00%0.0%
Q2 2021$36,322,000
-29.6%
7,093,827
-7.4%
0.00%
-50.0%
Q1 2021$51,583,000
+52.4%
7,664,792
+3.5%
0.00%
+100.0%
Q4 2020$33,848,000
+4.8%
7,406,795
-11.0%
0.00%0.0%
Q3 2020$32,303,000
-21.9%
8,325,485
-4.2%
0.00%
-50.0%
Q2 2020$41,349,000
+27.8%
8,686,677
-6.6%
0.00%0.0%
Q1 2020$32,363,000
-28.5%
9,299,973
-1.0%
0.00%0.0%
Q4 2019$45,282,000
+107.4%
9,394,624
+24.8%
0.00%
+100.0%
Q3 2019$21,831,000
-52.4%
7,528,050
+17.7%
0.00%
-50.0%
Q2 2019$45,852,000
-44.6%
6,394,923
+9.4%
0.00%
-50.0%
Q1 2019$82,835,000
+1.1%
5,845,706
-3.4%
0.00%0.0%
Q4 2018$81,909,000
-37.8%
6,053,727
+2.1%
0.00%
-33.3%
Q3 2018$131,629,000
+38.1%
5,931,927
+2.1%
0.01%
+50.0%
Q2 2018$95,312,0005,808,0830.00%
Other shareholders
AMNEAL PHARMACEUTICALS INC shareholders Q1 2022
NameSharesValueWeighting ↓
Fosun International Ltd 21,521,301$90,819,89014.58%
Eversept Partners, LP 2,644,988$11,161,8490.94%
TPG GP A, LLC 12,328,767$52,027,3970.90%
Nantahala Capital Management 2,212,757$9,337,8350.80%
Rubric Capital Management LP 4,024,500$16,983,3900.64%
Hedges Asset Management LLC 84,600$357,0120.31%
Signature Wealth Management Partners, LLC 66,666$281,3310.28%
Tejara Capital Ltd 96,672$407,9560.23%
Tranquilli Financial Advisor LLC 71,414$301,3670.22%
EAM Investors, LLC 230,271$971,7440.19%
View complete list of AMNEAL PHARMACEUTICALS INC shareholders